| . | ROMICAT-II (N = 238) . |
|---|---|
| Age, years | 52.7 ± 8.0 |
| Female sex, n (%) | 96 (40.3) |
| BMI, kg/m2 | 29.1 ± 4.7 |
| Cardiovascular risk factors | |
| Hypertension, n (%) | 124 (52.1) |
| Diabetes mellitus, n (%) | 40 (16.8) |
| Dyslipidaemia, n (%) | 105 (44.1) |
| Former/current smoker, n (%) | 118 (49.6) |
| Family history of premature CAD, n (%) | 87 (36.6) |
| Number of cardiovascular risk factors, n (%) | |
| 0–1 | 81 (34.0) |
| 2–3 | 135 (56.7) |
| ≥4 | 22 (9.2) |
| TIMI score, n (%) | |
| 0 | 145 (60.9) |
| 1 | 72 (30.3) |
| 2 | 19 (8.0) |
| ≥3 | 2 (0.8) |
| Prior medication | |
| Aspirin, n (%) | 55 (23.1) |
| Beta-blocker, n (%) | 42 (17.7) |
| Statin, n (%) | 65 (27.3) |
| Non-invasive diagnostic testing | |
| Positive test, n (%) | 34/145 (23.5) |
| Positive CCTAa, n (%) | 30/117 (25.6) |
| Positive SPECTb, n (%) | 7/43 (16.3) |
| Clinical events | |
| ACS, n (%) | 18 (7.6) |
| AMI, n (%) | 5 (2.1) |
| UAP, n (%) | 13 (5.5) |
| . | ROMICAT-II (N = 238) . |
|---|---|
| Age, years | 52.7 ± 8.0 |
| Female sex, n (%) | 96 (40.3) |
| BMI, kg/m2 | 29.1 ± 4.7 |
| Cardiovascular risk factors | |
| Hypertension, n (%) | 124 (52.1) |
| Diabetes mellitus, n (%) | 40 (16.8) |
| Dyslipidaemia, n (%) | 105 (44.1) |
| Former/current smoker, n (%) | 118 (49.6) |
| Family history of premature CAD, n (%) | 87 (36.6) |
| Number of cardiovascular risk factors, n (%) | |
| 0–1 | 81 (34.0) |
| 2–3 | 135 (56.7) |
| ≥4 | 22 (9.2) |
| TIMI score, n (%) | |
| 0 | 145 (60.9) |
| 1 | 72 (30.3) |
| 2 | 19 (8.0) |
| ≥3 | 2 (0.8) |
| Prior medication | |
| Aspirin, n (%) | 55 (23.1) |
| Beta-blocker, n (%) | 42 (17.7) |
| Statin, n (%) | 65 (27.3) |
| Non-invasive diagnostic testing | |
| Positive test, n (%) | 34/145 (23.5) |
| Positive CCTAa, n (%) | 30/117 (25.6) |
| Positive SPECTb, n (%) | 7/43 (16.3) |
| Clinical events | |
| ACS, n (%) | 18 (7.6) |
| AMI, n (%) | 5 (2.1) |
| UAP, n (%) | 13 (5.5) |
ACS, acute coronary syndrome; AMI, acute myocardial infarction; BMI, body mass index; CAD, coronary artery disease; CCTA, coronary computed tomography angiography; SPECT, single-photon emission computed tomography; TIMI, thrombolysis in myocardial infarction; UAP, unstable angina pectoris.
aPositive coronary CTA: >50% luminal narrowing.
bPositive SPECT: evidence of stress-induced ischaemia defined as reversible myocardial perfusion defect.
| . | ROMICAT-II (N = 238) . |
|---|---|
| Age, years | 52.7 ± 8.0 |
| Female sex, n (%) | 96 (40.3) |
| BMI, kg/m2 | 29.1 ± 4.7 |
| Cardiovascular risk factors | |
| Hypertension, n (%) | 124 (52.1) |
| Diabetes mellitus, n (%) | 40 (16.8) |
| Dyslipidaemia, n (%) | 105 (44.1) |
| Former/current smoker, n (%) | 118 (49.6) |
| Family history of premature CAD, n (%) | 87 (36.6) |
| Number of cardiovascular risk factors, n (%) | |
| 0–1 | 81 (34.0) |
| 2–3 | 135 (56.7) |
| ≥4 | 22 (9.2) |
| TIMI score, n (%) | |
| 0 | 145 (60.9) |
| 1 | 72 (30.3) |
| 2 | 19 (8.0) |
| ≥3 | 2 (0.8) |
| Prior medication | |
| Aspirin, n (%) | 55 (23.1) |
| Beta-blocker, n (%) | 42 (17.7) |
| Statin, n (%) | 65 (27.3) |
| Non-invasive diagnostic testing | |
| Positive test, n (%) | 34/145 (23.5) |
| Positive CCTAa, n (%) | 30/117 (25.6) |
| Positive SPECTb, n (%) | 7/43 (16.3) |
| Clinical events | |
| ACS, n (%) | 18 (7.6) |
| AMI, n (%) | 5 (2.1) |
| UAP, n (%) | 13 (5.5) |
| . | ROMICAT-II (N = 238) . |
|---|---|
| Age, years | 52.7 ± 8.0 |
| Female sex, n (%) | 96 (40.3) |
| BMI, kg/m2 | 29.1 ± 4.7 |
| Cardiovascular risk factors | |
| Hypertension, n (%) | 124 (52.1) |
| Diabetes mellitus, n (%) | 40 (16.8) |
| Dyslipidaemia, n (%) | 105 (44.1) |
| Former/current smoker, n (%) | 118 (49.6) |
| Family history of premature CAD, n (%) | 87 (36.6) |
| Number of cardiovascular risk factors, n (%) | |
| 0–1 | 81 (34.0) |
| 2–3 | 135 (56.7) |
| ≥4 | 22 (9.2) |
| TIMI score, n (%) | |
| 0 | 145 (60.9) |
| 1 | 72 (30.3) |
| 2 | 19 (8.0) |
| ≥3 | 2 (0.8) |
| Prior medication | |
| Aspirin, n (%) | 55 (23.1) |
| Beta-blocker, n (%) | 42 (17.7) |
| Statin, n (%) | 65 (27.3) |
| Non-invasive diagnostic testing | |
| Positive test, n (%) | 34/145 (23.5) |
| Positive CCTAa, n (%) | 30/117 (25.6) |
| Positive SPECTb, n (%) | 7/43 (16.3) |
| Clinical events | |
| ACS, n (%) | 18 (7.6) |
| AMI, n (%) | 5 (2.1) |
| UAP, n (%) | 13 (5.5) |
ACS, acute coronary syndrome; AMI, acute myocardial infarction; BMI, body mass index; CAD, coronary artery disease; CCTA, coronary computed tomography angiography; SPECT, single-photon emission computed tomography; TIMI, thrombolysis in myocardial infarction; UAP, unstable angina pectoris.
aPositive coronary CTA: >50% luminal narrowing.
bPositive SPECT: evidence of stress-induced ischaemia defined as reversible myocardial perfusion defect.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
